Endocrinology Guide: Diabetes, Thyroid Disorders, and Hormone Management

What Is Endocrinology?

Endocrine disorders affect hundreds of millions worldwide; diabetes mellitus alone affects 537 million adults globally and is projected to reach 783 million by 2045, according to the International Diabetes Federation. Endocrinology is the branch of medicine specializing in the diagnosis and treatment of hormone disorders. The endocrine system—comprising glands including the pituitary, thyroid, adrenals, and pancreas—regulates metabolism, growth, reproduction, and mood through chemical messengers called hormones. Common endocrine conditions include diabetes mellitus, thyroid disorders, adrenal insufficiency, and polycystic ovary syndrome. Because hormones affect every organ system, endocrine disorders often produce widespread, seemingly unrelated symptoms.

How Does the Endocrine System Work?

The endocrine system coordinates over 50 hormones that regulate virtually every physiological process—from metabolism and growth to reproduction and stress response—through a network of glands and feedback loops. The endocrine system is the body's chemical messaging network. It consists of glands that produce hormones -- signaling molecules released into the bloodstream to regulate virtually every physiological process, from metabolism and growth to reproduction and mood. The major endocrine glands include the pituitary (often called the "master gland"), thyroid, parathyroids, adrenals, pancreas, ovaries, and testes.

Unlike the nervous system, which sends rapid electrical signals to specific targets, the endocrine system works more slowly but with broader reach. A single hormone released from one gland can affect cells throughout the entire body. This interconnected nature means that a disorder in one part of the endocrine system often has cascading effects elsewhere. For example, excess cortisol from the adrenal glands can raise blood sugar, thin the bones, suppress the immune system, and alter mood -- all simultaneously.

This guide focuses on three of the most commonly encountered areas of endocrinology in clinical practice: diabetes mellitus, thyroid disease, and corticosteroid therapy.

What Is Diabetes Mellitus?

Diabetes mellitus is a group of metabolic diseases characterized by chronically elevated blood glucose (blood sugar). It affects over 500 million people worldwide and is a leading cause of heart disease, kidney failure, blindness, and lower-limb amputation. Understanding diabetes begins with understanding insulin, a hormone produced by the beta cells of the pancreas.

After eating, the body breaks down carbohydrates into glucose, which enters the bloodstream. Rising blood glucose triggers the pancreas to release insulin. Insulin acts like a key, unlocking cells in the muscles, fat tissue, and liver so they can absorb glucose and use it for energy. Without sufficient insulin -- or when cells stop responding to it -- glucose accumulates in the blood, causing damage to blood vessels and organs over time.

Type 1 diabetes is an autoimmune condition in which the immune system destroys the insulin-producing beta cells. It typically appears in childhood or young adulthood and requires lifelong insulin therapy. Type 2 diabetes, which accounts for roughly 90 to 95 percent of all diabetes cases, is driven primarily by insulin resistance -- cells become less responsive to insulin, and the pancreas eventually cannot produce enough to compensate. Type 2 diabetes is strongly associated with excess body weight, physical inactivity, and genetic predisposition.

Gestational diabetes develops during pregnancy in women who did not previously have diabetes. It increases the risk of complications for both mother and child and is a strong predictor of future type 2 diabetes in the mother.

What Is HbA1c and How Is It Interpreted?

A 1% reduction in HbA1c (e.g., from 8% to 7%) is associated with a 21% reduction in diabetes-related deaths and a 14% reduction in myocardial infarction risk, according to the UKPDS landmark trial. Hemoglobin A1c (HbA1c) is a blood test that reflects average blood glucose levels over the preceding two to three months. It works by measuring the percentage of hemoglobin -- the oxygen-carrying protein in red blood cells -- that has glucose molecules attached to it. Because red blood cells live for approximately 120 days, HbA1c provides a time-averaged picture of glycemic control rather than a single-moment snapshot.

An HbA1c of less than 5.7 percent is considered normal. Values between 5.7 and 6.4 percent indicate prediabetes, and 6.5 percent or higher on two separate tests is diagnostic of diabetes. For most adults with diabetes, major guidelines recommend an HbA1c target of less than 7.0 percent, which corresponds to an estimated average glucose of approximately 154 mg/dL (8.6 mmol/L). Use the HbA1c Converter to translate any HbA1c percentage into estimated average glucose in both mg/dL and mmol/L.

However, HbA1c targets should be individualized. Younger patients with a long life expectancy and no significant cardiovascular disease may benefit from tighter control (below 6.5 percent), while older adults with multiple comorbidities, limited life expectancy, or a history of severe hypoglycemia may be better served by a less stringent target of 7.5 to 8.0 percent. The key principle is balancing the long-term benefits of glucose lowering against the immediate risks of hypoglycemia.

It is important to note that HbA1c can be inaccurate in certain conditions. Hemoglobin variants (such as sickle cell trait), iron deficiency anemia, recent blood transfusion, and chronic kidney disease can all affect the result. In these situations, alternative measures such as fructosamine or continuous glucose monitoring may provide more reliable information.

How Is Insulin Dosing Calculated?

Insulin therapy is used by approximately 100 million people worldwide; incorrect dosing accounts for nearly 30% of adverse drug events in hospitalized patients, making precise insulin calculation a patient safety priority. For people with type 1 diabetes and many with type 2 diabetes, insulin therapy is a cornerstone of management. Insulin regimens can range from a single daily injection of long-acting insulin to complex multi-dose protocols involving both basal (background) and bolus (mealtime) insulin.

Basal insulin (such as glargine or detemir) provides a steady, low level of insulin throughout the day and night, mimicking the pancreas's constant background secretion. Bolus insulin (such as lispro or aspart) is a rapid-acting insulin taken before meals to cover the glucose spike from food. The combination of basal and bolus insulin is called basal-bolus therapy and is the standard of care for type 1 diabetes.

An insulin correction factor, also called a sensitivity factor, tells a patient how much one unit of rapid-acting insulin will lower their blood glucose. It is commonly estimated using the "1800 rule" for rapid-acting insulin: divide 1800 by the patient's total daily insulin dose. Calculate your correction factor automatically with the Insulin Correction Factor Calculator. For example, if a patient takes 45 units of insulin per day, their correction factor is approximately 1800 divided by 45, which equals 40 mg/dL per unit. This means one unit of rapid-acting insulin should lower blood glucose by about 40 mg/dL.

The insulin-to-carbohydrate ratio is another essential concept. It defines how many grams of carbohydrate are covered by one unit of rapid-acting insulin. The "500 rule" provides an estimate: divide 500 by the total daily dose. Using the same 45-unit example, the ratio would be approximately 500 divided by 45, or about 11 grams of carbohydrate per unit of insulin.

These formulas are starting points. Individual responses vary considerably, and ratios must be refined through careful blood glucose monitoring and, increasingly, through data from continuous glucose monitors.

What Are Thyroid Disorders?

Thyroid disorders affect approximately 200 million people worldwide, making thyroid disease the second most common endocrine disorder after diabetes; women are 5–8 times more likely to develop thyroid problems than men. The thyroid gland, a butterfly-shaped organ at the base of the neck, produces two primary hormones: thyroxine (T4) and triiodothyronine (T3). These hormones regulate the body's metabolic rate, influencing heart rate, body temperature, energy expenditure, and the function of nearly every organ system. Thyroid function is controlled by a feedback loop involving the hypothalamus, pituitary gland, and the thyroid itself. The pituitary releases thyroid-stimulating hormone (TSH), which signals the thyroid to produce T4 and T3. When thyroid hormone levels are adequate, TSH production decreases; when they are low, TSH rises.

Hypothyroidism -- an underactive thyroid -- is the more common disorder, affecting an estimated 5 percent of the adult population. Hashimoto's thyroiditis, an autoimmune condition in which the immune system attacks the thyroid gland, is the most common cause in iodine-sufficient countries. Symptoms of hypothyroidism develop gradually and can include fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, depression, and cognitive slowing. Because these symptoms overlap with many other conditions and with normal aging, hypothyroidism is often diagnosed through routine blood work rather than symptom-based suspicion alone.

Hyperthyroidism -- an overactive thyroid -- occurs when the gland produces excess thyroid hormone. Graves' disease, another autoimmune condition, is the most common cause. Symptoms include unintentional weight loss, rapid or irregular heartbeat, heat intolerance, tremor, anxiety, and eye changes (in Graves' disease specifically). Untreated hyperthyroidism can lead to atrial fibrillation, osteoporosis, and thyroid storm, a rare but life-threatening crisis.

How Is TSH Interpreted?

TSH is abnormal in approximately 10% of the general population and in up to 25% of older women, making it one of the most commonly detected laboratory abnormalities in routine health screening. TSH is the most sensitive first-line test for evaluating thyroid function. The normal reference range is typically 0.4 to 4.0 mIU/L, though this can vary slightly between laboratories. A high TSH with a low free T4 confirms primary hypothyroidism. A low TSH with a high free T4 or free T3 indicates hyperthyroidism. Use the TSH Interpreter to classify your TSH and free T4 results and identify subclinical or overt thyroid conditions. When TSH is abnormal but free T4 is still within the normal range, the condition is termed subclinical -- subclinical hypothyroidism (elevated TSH, normal free T4) or subclinical hyperthyroidism (suppressed TSH, normal free T4).

The decision to treat subclinical thyroid disease is nuanced. Subclinical hypothyroidism with a TSH above 10 mIU/L is generally treated with levothyroxine, as progression to overt hypothyroidism is common. For TSH levels between 4.0 and 10 mIU/L, treatment decisions consider the presence of symptoms, thyroid antibodies, cardiovascular risk factors, and patient preference. Subclinical hyperthyroidism carries a risk of atrial fibrillation and osteoporosis, particularly in older adults, and may warrant treatment depending on the degree of TSH suppression and the patient's overall risk profile.

Certain conditions can alter TSH independent of true thyroid disease. These include pregnancy (TSH normally decreases in the first trimester), acute illness (the "sick euthyroid" phenomenon), pituitary disorders, and medications such as biotin supplements, which can directly interfere with the TSH assay.

How Is Levothyroxine Dosed?

Levothyroxine is among the top 3 most prescribed medications in the United States, with approximately 23 million annual prescriptions, reflecting the high prevalence of hypothyroidism especially in women over 60. Levothyroxine (synthetic T4) is the standard treatment for hypothyroidism and one of the most commonly prescribed medications in the world. It replaces the missing thyroid hormone and, once the correct dose is established, provides stable hormone levels with once-daily dosing.

The typical starting dose for full replacement in healthy adults is 1.6 mcg per kilogram of body weight per day. For a 70 kg adult, this would be approximately 112 mcg daily, often rounded to an available tablet strength such as 100 or 125 mcg. Estimate a starting dose with the Levothyroxine Dose Calculator. However, older patients and those with cardiac disease should start at lower doses (25 to 50 mcg daily) and titrate gradually, because a sudden increase in metabolic rate can stress the heart.

Levothyroxine is best absorbed on an empty stomach. Patients are typically advised to take it 30 to 60 minutes before breakfast with a full glass of water. Calcium supplements, iron supplements, proton pump inhibitors, and certain foods can interfere with absorption and should be separated by at least four hours. After initiating or adjusting a dose, TSH is rechecked in six to eight weeks. Once stable, annual monitoring is usually sufficient.

How Are Corticosteroid Doses Converted?

Corticosteroids are prescribed to approximately 1% of the total population at any given time and to over 2.5% of adults, making corticosteroid dose conversion and tapering a routine clinical skill. Corticosteroids are synthetic versions of cortisol, a hormone produced by the adrenal glands. They are among the most widely prescribed drug classes in medicine, used to treat conditions ranging from asthma and allergies to autoimmune diseases, inflammatory bowel disease, and organ transplant rejection. Their therapeutic effects stem from their potent anti-inflammatory and immunosuppressive properties.

Not all corticosteroids are equally potent, and clinicians frequently need to convert between them. The concept of glucocorticoid equivalency uses hydrocortisone as the reference standard. Common equivalencies include: 20 mg hydrocortisone equals 5 mg prednisone equals 4 mg methylprednisolone equals 0.75 mg dexamethasone. Understanding these conversions is essential when switching between agents or when comparing doses described in clinical studies. Use the Steroid Equivalency Converter to convert between any two corticosteroids instantly.

Beyond anti-inflammatory potency, corticosteroids differ in their mineralocorticoid activity (affecting salt and water balance), duration of action, and route of administration. Hydrocortisone has significant mineralocorticoid effect and is preferred for adrenal replacement therapy, where mimicking the body's natural cortisol is the goal. Dexamethasone has virtually no mineralocorticoid effect, the longest duration of action, and the highest anti-inflammatory potency, making it preferred for situations like cerebral edema or certain chemotherapy protocols.

What Is Adrenal Insufficiency?

Adrenal insufficiency affects approximately 1 in 8,000 people, but adrenal crisis—a life-threatening emergency requiring immediate hydrocortisone—occurs at a rate of 5–10 episodes per 100 patient-years in those with known disease. The adrenal glands sit atop each kidney and produce cortisol, aldosterone, and androgens. Primary adrenal insufficiency (Addison's disease) results from destruction of the adrenal cortex itself, most commonly due to autoimmune adrenalitis. Secondary adrenal insufficiency is far more common and typically results from chronic exogenous corticosteroid use, which suppresses the hypothalamic-pituitary-adrenal (HPA) axis. When long-term steroids are abruptly discontinued, the adrenal glands cannot respond quickly enough, leading to cortisol deficiency.

Symptoms of adrenal insufficiency include fatigue, weakness, weight loss, nausea, abdominal pain, low blood pressure, and, in primary disease, skin hyperpigmentation. Adrenal crisis is a medical emergency characterized by severe hypotension, dehydration, and electrolyte abnormalities that can be fatal without prompt treatment with intravenous hydrocortisone and fluid resuscitation.

For patients on chronic corticosteroid therapy, tapering the dose gradually rather than stopping abruptly allows the HPA axis to recover. Patients with known adrenal insufficiency should carry medical identification and understand the concept of "stress dosing" -- temporarily increasing their corticosteroid dose during illness, surgery, or other physiological stress when the body would normally produce extra cortisol.

When to Seek Medical Attention

Endocrine disorders often develop slowly, and early symptoms can be subtle. However, certain warning signs warrant prompt medical evaluation: persistent unexplained weight changes, excessive thirst or urination, heat or cold intolerance that is new or worsening, a visible neck swelling or thyroid nodule, persistent fatigue not explained by sleep or lifestyle factors, and symptoms of adrenal crisis (severe weakness, dizziness, vomiting, or confusion -- especially in someone taking chronic steroids who has missed doses).

The tools on this site are designed to help patients and healthcare professionals understand endocrine laboratory values and medication dosing. They are educational aids and should always be used in conjunction with professional medical advice tailored to the individual patient's circumstances.